Synthesis of 9-oxime-11,12-carbamate ketolides through a novel N-deamination reaction of 11,12-hydrazonocarbamate ketolide

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 11, 2003, Pages 2389-2394

  Denis, Alexis ^a,b   Pejac, Jean Marie ^a   Bretin, François ^a   Bonnefoy, Alain ^a  

^a SANOFI   (France)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11,12 HYDRAZONOCARBAMATE; ALDEHYDE DERIVATIVE; CARBAMIC ACID DERIVATIVE; ERYTHROMYCIN; GLYCOALDEHYDE; KETOLIDE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DEAMINATION; DRUG SYNTHESIS; HYDROGEN BOND; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 0037624824     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00147-0     Document Type: Article

References (16)

1. Bryskier, A. J.; Butzler, J.-P.; Neu, H. C.; Tulkens, P. M., Eds.; Macrolides: Chemistry, Pharmacology and Clinical Uses. Arnette Blackwell: Paris, 1993.
2. (a) Amsden G.W. J. Antimicrob. Chemother. 44:1999;1 (b) Perez-Trallero E. J. Antimicrob. Chemother. 45:2000;401.
3. (b) Perez-Trallero, E. J. Antimicrob. Chemother. 1999, 44, 1
4. (a) For recent reviews, see: Schönfeld, W.; Kirst, H. A., Eds., Macrolide Antibiotics. Birhäuser: Basel, 2002, p 97. (b) Kaneko T., McArthur H., Sutcliffe J. Exp. Opin. Ther. Patents. 10:2000;403.
5. Denis A., Agouridas C., Auger J.-M., Benedetti Y., Bonnefoy A., Bretin F., Chantot J.-F., Dussarat A., Fromentin C., Gouin D'Ambrières S., Lachaud S., Laurin P., Le Martret O., Loyau V., Tessot N., Pejac J.-M., Perron S. Biorg. Med. Chem, Lett. 9:1999;3075.
6. Or Y.S., Clark R.F., Wang S., Chu D.T., Nilius A.M., Flamm R.K., Mitten M., Ewing P., Alder J., Ma Z. J. Med. Chem. 43:2000;1045.
7. Barman Balfour J.A., Figgitt D.P. Drug. 61:2001;815.
8. Agouridas C., Denis A., Auger J.-M., Benedetti Y., Bonnefoy A., Bretin F., Chantot J.-F., Dussarat A., Fromentin C., Gouin D'Ambrières S., Lachaud S., Laurin P., Le Martret O., Loyau V., Tessot N. J. Med. Chem. 41:1998;4080.
9. (a) Agouridas, C.; Denis, A.; Chantot, J.-F.; Fromentin, C.; Pejac, J.-M. WO Patent 9838199, 1998. (b) Kaneko, T.; McMillen, W. T. WO Patent 200044761, 2000.
10. (a) Agouridas, C.; Denis, A.; Chantot, J.-F.; Fromentin, C.; Pejac, J.-M. WO Patent 9838199, 1998. (b) Kaneko, T.; McMillen, W. T. WO Patent 200044761, 2000.
11. Stereochemistry of oxime confirmed by NMR according to ref Gasc J.C., Gouin d'Ambrières S., Lutz A., Chantot J.F. New ether oxime of erythromycin A and: a structure activity relationship study. J. Antibiot. 44:1991;313.
12. Evans D.A., Johnson D.S. Organic Lett. 1:1999;595.
13. Gmeiner P., Bollinger B., Mierau J., Höfner G. Arch. Pharm. 328:1995;609.
14. Atkinson R.S., Judkins B.D. J. Chem. Soc., Perkin Trans. 1981;509.
15. Milcent R., Guevrekian-Soghomoniantz M., Barbier G. J. Heterocycl. Chem. 23:1986;1845.
16. Denis A., Bretin F., Fromentin C., Bonnet A., Piltan G., Agouridas C., Bonnefoy A. Bioorg. Med. Chem. Lett. 2000;2019.